Effects of Statin Treatments on Coronary Plaques Assessed by Volumetric Virtual Histology Intravascular Ultrasound Analysis

JACC: Cardiovascular Interventions

Volumn 2, Issue 7, 2009, Pages 679-688

  Hong, Myeong Ki ^a   Park, Duk Woo ^b   Lee, Cheol Whan ^b   Lee, Seung Whan ^b   Kim, Young Hak ^b   Kang, Duk Hyun ^b   Song, Jae Kwan ^b   Kim, Jae Joong ^b   Park, Seong Wook ^b   Park, Seung Jung ^b  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

coronary disease; plaque; ultrasonics

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE; ROSUVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; VOLUMETRY;

AGED; CALCINOSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FIBROSIS; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NECROSIS; PREDICTIVE VALUE OF TESTS; PYRIMIDINES; SEVERITY OF ILLNESS INDEX; SIMVASTATIN; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; USER-COMPUTER INTERFACE;

EID: 67650590887     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.03.015     Document Type: Article

References (19)

1. Heart Protection Study Collaborative Group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo controlled trial. Lancet 360 (2002) 7-22
2. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
3. Cannon C.P., Braunwald E., McCabe C.H., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
4. Jukema J.W., Bruschke A.V., van Boven A.J., et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91 (1995) 2528-2540
5. MAAS investigators. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 344 (1994) 633-638
6. Nissen S.E., Nicholls S.J., Sipahi I., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID Trial. JAMA 295 (2006) 1556-1565
7. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291 (2004) 1071-1080
8. Okazaki S., Yokoyama T., Miyauchi K., et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study. Circulation 110 (2004) 1061-1068
9. Nair A., Kuban B.D., Tuzcu E.M., Schoenhagen P., Nissen S.E., and Vince G. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106 (2002) 2200-2206
10. Rodriguez-Granillo G.A., García-García H.M., Mc Fadden E.P., et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol 46 (2005) 2038-2042
11. Nasu K., Tsuchikane E., Katoh O., et al. Accuracy of in vivo coronary plaque morphology assessment. A validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 47 (2006) 2405-2412
12. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part 1. Circulation 108 (2003) 1664-1672
13. Virmani R., Burke A.P., Farb A., and Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 47 (2006) C13-C18
14. Libby P., Schoenbeck U., Mach F., Selwyn A.P., and Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 104 Suppl (1998) 14S-18S
15. Mintz G.S., Nissen S.E., Anderson W.D., et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37 (2001) 1478-1492
16. Jones P.H., Davidson M.H., Stein E.A., et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). Am J Cardiol 92 (2003) 152-160
17. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III Guidelines. Circulation 110 (2004) 227-239
18. Rodriguez-Granillo G.A., Agostoni P., Garcia-Garcia H.M., et al. Meta-analysis of the studies assessing temporal changes in coronary plaque volume using intravascular ultrasound. Am J Cardiol 99 (2007) 5-10
19. Hong M.K., Lee C.W., Kim Y.H., et al. Usefulness of follow-up low density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy. Am J Cardiol 98 (2006) 866-870